Prevalence and predictors of adverse events following exposure to long-lasting insecticidal nets used for malaria prevention: a community based cross-sectional study in the Democratic Republic of the Congo.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
01 Feb 2023
Historique:
received: 04 05 2022
accepted: 16 01 2023
entrez: 2 2 2023
pubmed: 3 2 2023
medline: 4 2 2023
Statut: epublish

Résumé

Malaria morbidity and mortality increase in the Democratic Republic of the Congo (DRC) may be the consequence of the low utilization rate of long-lasting insecticidal nets (LLINs) resulting from poor compliance due to adverse events (AEs). This study aimed at determining the prevalence and predictors of AEs following the mass distribution of LLINs in the Kisantu Health Zone (KHZ), a high malaria-endemic region in the DRC. A community-based cross-sectional study embedded was conducted within a randomized controlled trial (RCT) after the mass distribution of LLINs in 30 villages located in DRC KHZ. A three-stage sampling method was used without replacement to select 1790 children. Data was collected on adverse events (AEs) using a reporting form and information on demographics, nutritional status, and house characteristics. This was done using a structured questionnaire administered to household heads. Logistic regression models were used to identify predictors of AEs following the mass distribution of LLINs. In a total of 1790 children enrolled, 17.8% (95% CI 16.1-19.7) experienced AEs. The most common AEs were respiratory-related (61%). Around 60% of AEs occurred within 24 h of use, and 51% were resolved without treatment. Sleeping under deltamethrin LLINs (Adjusted OR, 95% CI 5.5 [3.8-8.0]) and zinc roofing (Adjusted OR, 95% CI 1.98 [1.1-3.57]) were associated with the risk of reporting an AE following the mass distribution of LLINs. Approximately 1 out of 5 children had an AE within 24 h following LLIN use. These adverse events were often respiratory-related. LLINs and roofing types were associated with a higher risk of reporting AEs. However, further research using a robust study design is needed to confirm these findings. Future studies should design and implement interventions aiming to reduce AEs and improve compliance with LLINs.

Sections du résumé

BACKGROUND BACKGROUND
Malaria morbidity and mortality increase in the Democratic Republic of the Congo (DRC) may be the consequence of the low utilization rate of long-lasting insecticidal nets (LLINs) resulting from poor compliance due to adverse events (AEs). This study aimed at determining the prevalence and predictors of AEs following the mass distribution of LLINs in the Kisantu Health Zone (KHZ), a high malaria-endemic region in the DRC.
METHODS METHODS
A community-based cross-sectional study embedded was conducted within a randomized controlled trial (RCT) after the mass distribution of LLINs in 30 villages located in DRC KHZ. A three-stage sampling method was used without replacement to select 1790 children. Data was collected on adverse events (AEs) using a reporting form and information on demographics, nutritional status, and house characteristics. This was done using a structured questionnaire administered to household heads. Logistic regression models were used to identify predictors of AEs following the mass distribution of LLINs.
RESULT RESULTS
In a total of 1790 children enrolled, 17.8% (95% CI 16.1-19.7) experienced AEs. The most common AEs were respiratory-related (61%). Around 60% of AEs occurred within 24 h of use, and 51% were resolved without treatment. Sleeping under deltamethrin LLINs (Adjusted OR, 95% CI 5.5 [3.8-8.0]) and zinc roofing (Adjusted OR, 95% CI 1.98 [1.1-3.57]) were associated with the risk of reporting an AE following the mass distribution of LLINs.
CONCLUSION CONCLUSIONS
Approximately 1 out of 5 children had an AE within 24 h following LLIN use. These adverse events were often respiratory-related. LLINs and roofing types were associated with a higher risk of reporting AEs. However, further research using a robust study design is needed to confirm these findings. Future studies should design and implement interventions aiming to reduce AEs and improve compliance with LLINs.

Identifiants

pubmed: 36726181
doi: 10.1186/s12936-023-04458-w
pii: 10.1186/s12936-023-04458-w
pmc: PMC9893672
doi:

Substances chimiques

Insecticides 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35

Informations de copyright

© 2023. The Author(s).

Références

Trans R Soc Trop Med Hyg. 2013 Jan;107(1):8-14
pubmed: 23222943
J Vector Borne Dis. 2013 Sep;50(3):206-14
pubmed: 24220080
Exp Appl Acarol. 2016 Jan;68(1):71-82
pubmed: 26530989
Pan Afr Med J. 2016 Mar 16;23:101
pubmed: 27222690
J Nutr. 2009 Apr;139(4):763-72
pubmed: 19225131
Cochrane Database Syst Rev. 2018 Nov 29;11:CD012776
pubmed: 30488945
Malar J. 2020 May 24;19(1):189
pubmed: 32448213
MMWR Morb Mortal Wkly Rep. 2011 Sep 23;60(37):1269-74
pubmed: 21937972
Malar J. 2018 Nov 6;17(1):412
pubmed: 30400885
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Int J Environ Res Public Health. 2019 Jul 20;16(14):
pubmed: 31330765
Acta Trop. 1991 Jun;49(2):87-96
pubmed: 1680283

Auteurs

Gillon Ilombe (G)

Unit of Entomology, Department of Parasitology, National Institute of Biomedical Research, Kinshasa, Democratic Republic of the Congo. gillonilombe@yahoo.fr.
Unit of Clinical Pharmacology and Pharmacovigilance, Department of Base Science, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo. gillonilombe@yahoo.fr.
Faculty of Medicine, Global Health Institute, Antwerp University, Antwerp, Belgium. gillonilombe@yahoo.fr.

Thérèse Mpiempie (T)

Unit of Clinical Pharmacology and Pharmacovigilance, Department of Base Science, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Gauthier Mesia (G)

Unit of Clinical Pharmacology and Pharmacovigilance, Department of Base Science, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Junior R Matangila (JR)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Aimée M Lulebo (AM)

Faculty of Medicine, Public Health School, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Vivi Maketa (V)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Baby Mabanzila (B)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Nicole M Muela (NM)

Expanded on Inoculation Logistic Section, Ministry of Public Health Kinshasa, Kinshasa, Democratic Republic of the Congo.

Flory T Muanda (FT)

Unit of Clinical Pharmacology and Pharmacovigilance, Department of Base Science, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
ICES, Toronto, ON, Canada.
Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.

Sylvie Linsuke (S)

Faculty of Medicine, Global Health Institute, Antwerp University, Antwerp, Belgium.
Department of Epidemiology, National Institute of Biomedical Research, Kinshasa, Democratic Republic of the Congo.

Jean-Pierre van Geertruyden (JP)

Faculty of Medicine, Global Health Institute, Antwerp University, Antwerp, Belgium.

Pascal Lutumba (P)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH